Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MetD-AO

Financiado

Methyl Donating artificial organelles to support liver cells in Non alcoholic fa...

Methyl Donating artificial organelles to support liver cells in Non alcoholic fatty liver disease Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, encompassing a spectrum of liver damage. Multiple issues are involved on the cellular level in failing liver often including e... ver más

31/08/2021

219K€

Presupuesto del proyecto: 219K€

Líder del proyecto

AARHUS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-08-31

MSCA-IF-2018: Individual Fellowships

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

219.31K€ | Lider

FELGUERA MELT, S.A.

665.64K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NanoACATre Rational Design of ACAT Single Enzyme Nanogels for Hepatic F... 215K€ Cerrado

PRE2020-094885 OPCIONES TERAPEUTICAS DE LA CICLOOXIGENASA 2 EN LA ENFERMEDA... 99K€ Cerrado

RTI2018-094734-B-C21 UTILIDAD TERAPEUTICA Y DE NUEVOS TRATAMIENTOS PARA LAS ENFER... 230K€ Cerrado

PDC2022-133780-C22 NUEVAS NANOTERAPIAS INDUSTRIALMENTE ESCALABLES PARA TRATAR L... 75K€ Cerrado

RTI2018-094734-B-C22 DESARROLLO DE NANOPARTICULAS DE POLI(BETA-AMINOESTER) CON CA... 109K€ Cerrado

PID2021-126096NB-I00 REMODELACION DEL METABOLISMO DE GLUCOSA Y LIPIDOS EN CELULAS... 424K€ Cerrado

Duración del proyecto: 28 meses Fecha Inicio: 2019-04-12
Fecha Fin: 2021-08-31

Líder del proyecto

AARHUS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 219K€

Descripción del proyecto Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, encompassing a spectrum of liver damage. Multiple issues are involved on the cellular level in failing liver often including enzyme deficiencies such as reduced biosynthesis of S-adenosylmethionine (SAMe). Preserving SAMe homeostasis has only recently started to be considered as a potential therapeutic target in liver-related medical conditions. However, employing the required enzyme, SAMe synthetase (SAMe-synth), as a pharmaceutical, is challenging due to the general issues involved in intact (functional) protein delivery. The aim of the MetD-AO project is to assemble organic SAMe-synth activity mimicking polymer nanoparticles as artificial organelles (AO) and their in vitro characterization of intracellular function in hepatocytes. AOs are typically nano-sized single compartment reactors, aimed to perform a specific encapsulated biocatalytic reaction within a cell to substitute for missing or lost function. The AO will be based on amphiphilic copolymers consisting of a methyl-donating unit, cholesterol methacrylate and poly(5-carboxypentyl acrylate) as membranolytic hydrophilic tail. The latter two will aim at facilitating self-assembly and lysosomal escape, respectively. To allow structurally intact AO to escape the lysosome is unique since typically, the carrier is destroyed and only the therapeutic cargo is release into the cytosol. The proposed AOs with methyl-donating ability are highly advanced because the few prior reported AOs with intracellular activity all considered reactive oxygen related aspects at best. The successful outcome of MetD-AO has the potential to open up entirely new therapeutic opportunities in NAFLD. The complementary expertise of my host Dr. Stadler and me, a trained polymer chemist, will ensure a successful conduction of MetD-AO while it will enhance my future career prospects gaining experience in colloidal science and cell biology.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores